Electrocardiographic and biochemical adverse effects of meglumine antimoniate (MA) during treatment of Syrian cutaneous leishmaniasis patients. (2016). Journal of Pakistan Association of Dermatologists, 23(4), 412-417. https://doi.org/10.66344/jpad.v23i4.289